Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a Canada-based practitioner-focused digital healthcare company. Its healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. Its business units include Canadian Patient Services, WELL Health USA Patient and Provider Services, and SaaS and Technology Services... see more

TSX:WELL - Post Discussion

View:
Post by retiredcf on Mar 16, 2021 9:15am

CRH Earnings

08:31 AM EDT, 03/16/2021 (MT Newswires) -- CRH Medical Corporation (CRH.TO) reported (in US$) Q4 2020 total revenue of $36.8 million, an increase of 21% from Q4 2019. Anesthesia services revenue was $34.1 million, a 24% increase from Q4 2019.

Anesthesia patient cases were 108,681,15% increase YoY.

The company reported operating income of $3.8 million, compared with $2.55 million for the year ago quarter.

Tushar Ramani, CEO, said "We are pleased to report record fourth quarter revenue and shareholder EBITDA as the impact of COVID-19 on the facilities we serve has abated and they have returned to and remained at normal operating levels, yielding healthy organic growth in anesthesia case volumes and strong acquisition activity in the latter half of 2020. As we progress in 2021, we look forward to sustained operating volumes and continued execution of our market strategies."

Price: 4.8500, Change: 0.0000, Percent Change: 0.00

Comment by monty613 on Mar 16, 2021 10:36am
I think the key here is the strong Adj EBITDA to SH - the full year was obviously impacted by COVID but a run rate of ~$40MM/year is huge for WELL and will give the company some cashflow to leverage in the form of more debt for acquisitions Fourth quarter 2020 highlights (all results expressed in USD): Total revenue of $36.8 million, an increase of 21% from fourth quarter 2019 ...more